This free one hour webcast will be presented by Dr. Elizabeth Vadas, InSciTech
Once a new molecule with the desired biological and pharmacological properties is discovered and declared a “development candidate” many disciplines must swing into action; preclinical development, CMC, regulatory and clinical research to name a few. Whether the company is a large, integrated pharmaceutical company or a small biotech with no or limited development expertise, the activities must be well coordinated since many of them run in parallel. This presentation will highlight the complex processes and activities and their interdependency. Ultimately the development activities must result in a safe, well tolerated, efficacious and commercially viable therapeutic product.